TADLIQ

NDC 46287-045 · CMP Pharma, Inc.

Generic nameTadalafil

Dosage formSUSPENSION

RouteORAL

Active ingredient(s)TADALAFIL

Strength20 mg/5mL

Pharmacologic classPhosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]

Marketing categoryNDA

Packages

46287-045-15 — 150 mL in 1 BOTTLE (46287-045-15)

FDA lists these products with the same active ingredient.

43547-047 — tadalafil, 43547-049 — tadalafil, 43547-050 — tadalafil, 43547-051 — tadalafil, 43547-990 — tadalafil, 43598-573 — Tadalafil, 43598-574 — Tadalafil, 43598-575 — Tadalafil, 43598-576 — Tadalafil, 43598-578 — Tadalafil, 46708-177 — tadalafil, 46708-178 — tadalafil, 46708-179 — tadalafil, 46708-180 — tadalafil, 47335-009 — Tadalafil, 47335-010 — Tadalafil, 47335-011 — Tadalafil, 47335-012 — Tadalafil, 50090-4660 — Tadalafil, 50090-5641 — Tadalafil, +230 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.